Trademark: 88899914
Word
BELAMAF
Status
Registered
Status Code
700
Status Date
Tuesday, November 23, 2021
Serial Number
88899914
Registration Number
6565117
Registration Date
Tuesday, November 23, 2021
Mark Type
4000
Filing Date
Monday, May 4, 2020
Published for Opposition
Tuesday, September 7, 2021

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders
BELANTAMAB MAFODOTIN

Trademark Events
Jun 27, 2023
Teas Change Of Correspondence Received
Jun 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 27, 2023
Teas Change Of Owner Address Received
Oct 28, 2022
Teas Change Of Correspondence Received
Oct 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 23, 2021
Registered-Principal Register
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Aug 5, 2021
Approved For Pub - Principal Register
Aug 5, 2021
Examiner's Amendment Entered
Aug 5, 2021
Notification Of Examiners Amendment E-Mailed
Aug 5, 2021
Examiners Amendment E-Mailed
Aug 5, 2021
Examiners Amendment -Written
Jul 29, 2021
Teas/Email Correspondence Entered
Jul 29, 2021
Correspondence Received In Law Office
Jul 29, 2021
Assigned To Lie
Jul 27, 2021
Teas Response To Suspension Inquiry Received
Feb 1, 2021
Notification Of Inquiry As To Suspension E-Mailed
Feb 1, 2021
Inquiry To Suspension E-Mailed
Feb 1, 2021
Suspension Inquiry Written
Jul 30, 2020
Notification Of Letter Of Suspension E-Mailed
Jul 30, 2020
Letter Of Suspension E-Mailed
Jul 30, 2020
Suspension Letter Written
Jul 29, 2020
Assigned To Examiner
May 15, 2020
New Application Office Supplied Data Entered
May 7, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24